Effects of Zinc Oxide Nanoparticles in HUVEC: Cyto- and Genotoxicity and Functional Impairment After Long-Term and Repetitive Exposure in Vitro

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2020 Jul 2

PMID 32606688

Citations 7

Authors

Nikolaus Poier

Johannes Hochstoger

Stephan Hackenberg

Agmal Scherzad

Maximilian Bregenzer

Dominik Schopper

Norbert Kleinsasser

Affiliations

Soon will be listed here.

Abstract

Purpose: The present study focuses on threshold levels for cytotoxicity after long-term and repetitive exposure for HUVEC as a model for the specific microvascular endothelial system. Furthermore, possible genotoxic effects and functional impairment caused by ZnO NPs in HUVEC are elucidated.

Methods: Thresholds for cytotoxic effects are determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Annexin V assay. To demonstrate DNA damage, single-cell microgel electrophoresis (comet) assay is performed after exposure to sub-cytotoxic concentrations of ZnO NPs. The proliferation assay, dot blot assay and capillary tube formation assay are also carried out to analyze functional impairment.

Results: NPs showed to be spherical in shape with an average size of 45-55 nm. Long-term exposure as well as repetitive exposure with ZnO NPs exceeding 25 µg/mL lead to decreased viability in HUVEC. In addition, DNA damage was indicated by the comet assay after long-term and repetitive exposure. Twenty-four hours after long-term exposure, the proliferation assay does not show any difference between negative control and exposed cells. Forty-eight hours after exposure, HUVEC show an inverse concentration-related ability to proliferate. The dot blot assay provides evidence that ZnO NPs lead to a decreased release of VEGF, while capillary tube formation assay shows restriction in the ability of HUVEC to build tubes and meshes as a first step in angiogenesis.

Conclusion: Sub-cytotoxic concentrations of ZnO NPs lead to DNA damage and functional impairment in HUVEC. Based on these data, ZnO NPs may affect neo-angiogenesis. Further investigation based on tissue cultures is required to elucidate the impact of ZnO NPs on human cell systems.

Citing Articles

Transition metals in angiogenesis - A narrative review.

Durig J, Calcagni M, Buschmann J Mater Today Bio. 2023; 22:100757.

PMID: 37593220 PMC: 10430620. DOI: 10.1016/j.mtbio.2023.100757.

Copper and Zinc Particles as Regulators of Cardiovascular System Function-A Review.

Kitala K, Tanski D, Godlewski J, Krajewska-Wlodarczyk M, Gromadzinski L, Majewski M Nutrients. 2023; 15(13).

PMID: 37447366 PMC: 10346759. DOI: 10.3390/nu15133040.

Preparation of Novel Composites of Polyvinyl Alcohol Containing Hesperidin Loaded ZnO Nanoparticles and Determination of Their Biological and Thermal Properties.

Erol I, Hazman O, Aksu M J Inorg Organomet Polym Mater. 2023; 33(3):731-746.

PMID: 36694851 PMC: 9851736. DOI: 10.1007/s10904-023-02532-z.

High-Affinity Cu(I)-Chelator with Potential Anti-Tumorigenic Action-A Proof-of-Principle Experimental Study of Human H460 Tumors in the CAM Assay.

Heuberger D, Wolint P, Jang J, Itani S, Jungraithmayr W, Waschkies C Cancers (Basel). 2022; 14(20).

PMID: 36291910 PMC: 9600560. DOI: 10.3390/cancers14205122.

Experimental study on novel biodegradable Zn-Fe-Si alloys.

Zeng Y, Guan Z, Linsley C, Pan S, Liu J, Wu B J Biomed Mater Res B Appl Biomater. 2022; 110(10):2266-2275.

PMID: 35522226 PMC: 9378461. DOI: 10.1002/jbm.b.35075.

References

Sun J, Wang S, Zhao D, Hun F, Weng L, Liu H . Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells: cytotoxicity, permeability, and inflammation of metal oxide nanoparticles. Cell Biol Toxicol. 2011; 27(5):333-42. DOI: 10.1007/s10565-011-9191-9. View

Nemmar A, Vanbilloen H, Hoylaerts M, Hoet P, Verbruggen A, Nemery B . Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med. 2001; 164(9):1665-8. DOI: 10.1164/ajrccm.164.9.2101036. View

Osmond M, McCall M . Zinc oxide nanoparticles in modern sunscreens: an analysis of potential exposure and hazard. Nanotoxicology. 2010; 4(1):15-41. DOI: 10.3109/17435390903502028. View

Gulson B, McCall M, Korsch M, Gomez L, Casey P, Oytam Y . Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci. 2010; 118(1):140-9. DOI: 10.1093/toxsci/kfq243. View

Yan Z, Wang W, Wu Y, Wang W, Li B, Liang N . Zinc oxide nanoparticle-induced atherosclerotic alterations in vitro and in vivo. Int J Nanomedicine. 2017; 12:4433-4442. PMC: 5476650. DOI: 10.2147/IJN.S134897. View

Kim J, Jeong M, Kim D, Her S, Wie M . Zinc oxide nanoparticles induce lipoxygenase-mediated apoptosis and necrosis in human neuroblastoma SH-SY5Y cells. Neurochem Int. 2015; 90:204-14. DOI: 10.1016/j.neuint.2015.09.002. View

Scherzed A, Hackenberg S, Froelich K, Rak K, Schendzielorz P, Gehrke T . The differentiation of hMSCs counteracts their migration capability and pro-angiogenic effects in vitro. Oncol Rep. 2015; 35(1):219-26. DOI: 10.3892/or.2015.4383. View

Suzuki Y, Tada-Oikawa S, Ichihara G, Yabata M, Izuoka K, Suzuki M . Zinc oxide nanoparticles induce migration and adhesion of monocytes to endothelial cells and accelerate foam cell formation. Toxicol Appl Pharmacol. 2014; 278(1):16-25. DOI: 10.1016/j.taap.2014.04.010. View

Mirshojaei S, Ahmadi A, Morales-Avila E, Ortiz-Reynoso M, Reyes-Perez H . Radiolabelled nanoparticles: novel classification of radiopharmaceuticals for molecular imaging of cancer. J Drug Target. 2015; 24(2):91-101. DOI: 10.3109/1061186X.2015.1048516. View

10.

Nair S, Sasidharan A, Rani V, Menon D, Nair S, Manzoor K . Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci Mater Med. 2008; 20 Suppl 1:S235-41. DOI: 10.1007/s10856-008-3548-5. View

11.

Chuang K, Lee K, Pan C, Lai C, Lin L, Ho S . Effects of zinc oxide nanoparticles on human coronary artery endothelial cells. Food Chem Toxicol. 2016; 93:138-44. DOI: 10.1016/j.fct.2016.05.008. View

12.

Wang J, Gao S, Wang S, Xu Z, Wei L . Zinc oxide nanoparticles induce toxicity in CAL 27 oral cancer cell lines by activating PINK1/Parkin-mediated mitophagy. Int J Nanomedicine. 2018; 13:3441-3450. PMC: 6016020. DOI: 10.2147/IJN.S165699. View

13.

Sharma V, Shukla R, Saxena N, Parmar D, Das M, Dhawan A . DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol Lett. 2009; 185(3):211-8. DOI: 10.1016/j.toxlet.2009.01.008. View

14.

Kwon J, Lee S, Koedrith P, Lee J, Kim K, Oh J . Lack of genotoxic potential of ZnO nanoparticles in in vitro and in vivo tests. Mutat Res Genet Toxicol Environ Mutagen. 2014; 761:1-9. DOI: 10.1016/j.mrgentox.2014.01.005. View

15.

Saptarshi S, Duschl A, Lopata A . Biological reactivity of zinc oxide nanoparticles with mammalian test systems: an overview. Nanomedicine (Lond). 2015; 10(13):2075-92. DOI: 10.2217/nnm.15.44. View

16.

Sahu D, Kannan G, Vijayaraghavan R, Anand T, Khanum F . Nanosized zinc oxide induces toxicity in human lung cells. ISRN Toxicol. 2013; 2013:316075. PMC: 3749605. DOI: 10.1155/2013/316075. View

17.

Cross S, Innes B, Roberts M, Tsuzuki T, Robertson T, McCormick P . Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol. 2007; 20(3):148-54. DOI: 10.1159/000098701. View

18.

Song W, Zhang J, Guo J, Zhang J, Ding F, Li L . Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles. Toxicol Lett. 2010; 199(3):389-97. DOI: 10.1016/j.toxlet.2010.10.003. View

19.

Pokrowiecki R, Wojnarowicz J, Zareba T, Koltsov I, Lojkowski W, Tyski S . Nanoparticles And Human Saliva: A Step Towards Drug Delivery Systems For Dental And Craniofacial Biomaterials. Int J Nanomedicine. 2019; 14:9235-9257. PMC: 6886554. DOI: 10.2147/IJN.S221608. View

20.

Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2):55-63. DOI: 10.1016/0022-1759(83)90303-4. View